ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund-IDCW Payout
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund-IDCW Payout: Mutual Fund Overview
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund-IDCW Payout is an Sectoral-Pharma mutual fund with over 7.66 years of performance history. The scheme manages an AUM of ₹6801.16 Cr and has a NAV of ₹22.43. It is rated '5' stars by analysts. Investors can begin a SIP with as little as ₹100.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 10.2%.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 10.2% at 12 Mar 2026 07:12 PM
Fund Details
NAV 22.43
Sub-Type Sectoral-Pharma
Rating 5
Min. SIP Amount ₹100.0
Fund Age(Year) 7.66
Fund Size(in Crores) 6801.16
Fund Performance
1 Month -0.2%
3 Month -3.87%
6 Month -5.06%
1 Year 10.2%
3 Year 28.06%
5 Year 17.0%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (97.98%) Market Cap Large Cap 37.07 Mid Cap 25.36 Small Cap 35.56 Top Sectors Healthcare 95.5 Services 1.31 Chemicals 1.17 Top Holding Cipla 9.4 Sanofi Consumer Healthcare India 0.88 Aarti Drugs 0.98 Shilpa Medicare 0.97 Dr. Reddy's Laboratories 6.52 JB Chemicals 1.75 Senores Pharmaceuticals 0.71 Hikal 1.15 Alkem Laboratories 3.47 Mankind Pharma 7.64 Biocon 6.2 Blue Jet Healthcare 1.22 Laxmi Dental 0.63 Sun Pharma Adv Resrc 0.45 Anthem Biosciences 1.09 Entero Healthcare Solutions 1.46 Medi Assist Healthcare Services 1.31 Sun Pharmaceutical Industries 11.21 Windlas Biotech 0.95 Glenmark Pharmaceuticals 1.19 FDC 0.63 Pfizer 1.34 Fine Organic Industries 1.17 Aurobindo Pharma 3.7 Rubicon Research 0.26 Nephrocare Health Services 0.48 Divi's Laboratories 5.95 Lupin 3.99 Akums Drugs And Pharmaceuticals 1.77 Thyrocare Technologies 1.75 Medplus Health Services 2.54 Metropolis Healthcare 1.21 Alivus Life Sciences 2.11 Cohance Lifesciences 2.77 Astrazeneca Pharma India 0.76 Alembic Pharmaceuticals 1.6 Zydus Lifesciences 2.07 Syngene International 3.16 Gland Pharma 1.54
Debt & Others (2.02%) Sector Allocation Net Payables -0.19 Repo 2.18 Treasury Bills 0.03 Debt Credit Ratings Debt Category Reserve Bank of India 0.03 Others 1.99
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 1.86%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Dharmesh Kakkad
Education Mr. kakkad is B.com., CA & CFA.
Experience He is associated with ICICI Prudential Asset Management Company Limited from June 2010. Prior to working in Dealing function, he was working in the Operations Department of ICICI Prudential AMC.
Sharmila D'Silva
Education Ms. D'Silva is CA and BAF
Experience She joined ICICI Prudential AMC Limited in September 2016.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 27
Date of Incorporation 2018-07-13
Total AUM 1124266.03
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
